Hager Investment Management Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Sell
5,407
-463
-8% -$99.6K 0.63% 50
2026
Q1
$1.28M Sell
5,870
-671
-10% -$149K 0.7% 44
2025
Q4
$1.49M Sell
6,541
-268
-4% -$61.1K 0.82% 40
2025
Q3
$1.58M Buy
6,809
+1,771
+35% +$361K 0.85% 38
2025
Q2
$935K Buy
5,038
+38
+0.8% +$7.06K 0.56% 44
2025
Q1
$1.05M Sell
5,000
-56
-1% -$10.9K 0.73% 42
2024
Q4
$898K Buy
+5,056
New +$930K 0.56% 42

Other funds holding ABBV

Hager Investment Management Services's ABBV Position: Q2 2026 in Review

Hager Investment Management Services reduced its AbbVie (ABBV) stake by 7.9% in Q2 2026, selling an estimated $99.6K and leaving 5,407 shares worth $1.36M. The position accounts for 0.63% of the portfolio, ranked #50.

Hager Investment Management Services first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.58M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hager Investment Management Services held 5,407 shares of AbbVie worth $1.36M as of Q2 2026.
  • Hager Investment Management Services sold 463 AbbVie shares in Q2 2026, an estimated $99.6K.
  • AbbVie made up 0.63% of Hager Investment Management Services's portfolio in Q2 2026, its #50 holding.
  • Hager Investment Management Services first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Hager Investment Management Services's AbbVie position peaked at $1.58M in Q3 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hager Investment Management Services's 13F filing for Q2 2026, filed 20 Jul 2026.